Cargando…

Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart

Ischemia/reperfusion (I/R) of the heart becomes injurious when duration of the ischemic insult exceeds a certain threshold (approximately ≥20 min). Mitochondrial bound hexokinase II (mtHKII) protects against I/R injury, with the amount of mtHKII correlating with injury. Here, we examine whether mtHK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nederlof, Rianne, Gürel-Gurevin, Ebru, Eerbeek, Otto, Xie, Chaoqin, Deijs, G. Sjoerd, Konkel, Moritz, Hu, Jun, Weber, Nina C., Schumacher, Cees A., Baartscheer, Antonius, Mik, Egbert G., Hollmann, Markus W., Akar, Fadi G., Zuurbier, Coert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534207/ https://www.ncbi.nlm.nih.gov/pubmed/28258543 http://dx.doi.org/10.1007/s13105-017-0555-3

Ejemplares similares

Cyclophilin D ablation is associated with increased end-ischemic mitochondrial hexokinase activity
por: Nederlof, Rianne, et al.
Publicado: (2017)

Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
por: Balestra, Gianmarco M, et al.
Publicado: (2015)

Partial hexokinase II knockout results in acute ischemia–reperfusion damage in skeletal muscle of male, but not female, mice
por: Smeele, Kirsten M., et al.
Publicado: (2010)

Sodium-glucose co-transporter 2 inhibitor empagliflozin inhibits the cardiac Na(+)/H(+) exchanger 1: persistent inhibition under various experimental conditions
por: Zuurbier, Coert J, et al.
Publicado: (2021)

Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infarct Size in Presence of Fentanyl, Midazolam and Cangrelor, but Not Propofol
por: Xiao, Yang, et al.
Publicado: (2021)

Direct Cardiac Actions of Sodium Glucose Cotransporter 2 Inhibitors Target Pathogenic Mechanisms Underlying Heart Failure in Diabetic Patients
por: Uthman, Laween, et al.
Publicado: (2018)

The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury
por: Xiao, Yang, et al.
Publicado: (2021)

Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na(+)/H(+) exchanger, lowering of cytosolic Na(+) and vasodilation
por: Uthman, Laween, et al.
Publicado: (2017)

Empagliflozin decreases myocardial cytoplasmic Na(+) through inhibition of the cardiac Na(+)/H(+) exchanger in rats and rabbits
por: Baartscheer, Antonius, et al.
Publicado: (2016)

Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
por: Uthman, Laween, et al.
Publicado: (2020)

A randomized trial of remote ischemic preconditioning and control treatment for cardioprotection in sevoflurane-anesthetized CABG patients
por: Nederlof, Rianne, et al.
Publicado: (2017)

Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells
por: Chen, Sha, et al.
Publicado: (2023)

Deletion of the Innate Immune NLRP3 Receptor Abolishes Cardiac Ischemic Preconditioning and Is Associated with Decreased Il-6/STAT3 Signaling
por: Zuurbier, Coert J., et al.
Publicado: (2012)

NLRX1 Deletion Increases Ischemia-Reperfusion Damage and Activates Glucose Metabolism in Mouse Heart
por: Zhang, Hong, et al.
Publicado: (2020)

Pharmacological Cardioprotection against Ischemia Reperfusion Injury—The Search for a Clinical Effective Therapy
por: Wang, Qian, et al.
Publicado: (2023)

Helium alters the cytoskeleton and decreases permeability in endothelial cells cultured in vitro through a pathway involving Caveolin-1
por: Smit, Kirsten F., et al.
Publicado: (2018)

Direct cardiac effects of SGLT2 inhibitors
por: Chen, Sha, et al.
Publicado: (2022)

The Driving Force of the Na(+)/Ca(2+)-Exchanger during Metabolic Inhibition
por: Baartscheer, Antonius, et al.
Publicado: (2011)

Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?
por: Zuurbier, Coert J.
Publicado: (2020)

Effects of N-acetylcysteine (NAC) supplementation in resuscitation fluids on renal microcirculatory oxygenation, inflammation, and function in a rat model of endotoxemia
por: Ergin, Bulent, et al.
Publicado: (2016)

Ascorbic acid improves renal microcirculatory oxygenation in a rat model of renal I/R injury
por: Ergin, Bulent, et al.
Publicado: (2015)

Amelioration of endothelial dysfunction by sodium glucose co‐transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection
por: Li, Xiaoling, et al.
Publicado: (2022)

Suspended animation inducer hydrogen sulfide is protective in an in vivo model of ventilator-induced lung injury
por: Aslami, Hamid, et al.
Publicado: (2010)

A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers
por: Xu, Shili, et al.
Publicado: (2018)

Mitochondrial Dysfunction: A New Frontier in the Search for Elusive Arrhythmia Mechanisms
por: Xie, Chaoqin, et al.
Publicado: (2010)

Cardioprotective efficacy depends critically on pharmacological dose, duration of ischaemia, health status of animals and choice of anaesthetic regimen: a case study with folic acid
por: Zuurbier, Coert J, et al.
Publicado: (2014)

Hexokinase 2 as oncotarget
por: Patra, Krushna C., et al.
Publicado: (2013)

Increasing accuracy of pulse transit time measurements by automated elimination of distorted photoplethysmography waves
por: van Velzen, Marit H. N., et al.
Publicado: (2017)

Moonlighting Proteins: The Case of the Hexokinases
por: Rodríguez-Saavedra, Carolina, et al.
Publicado: (2021)

Hexokinases in cancer and other pathologies
por: Guo, Dong, et al.
Publicado: (2023)

Functional crosstalk between the mitochondrial PTP and K(ATP) channels determine arrhythmic vulnerability to oxidative stress
por: Xie, Chaoqin, et al.
Publicado: (2014)

Modeling non‐linear kinetics of hyperpolarized [1‐(13)C] pyruvate in the crystalloid‐perfused rat heart
por: Mariotti, E., et al.
Publicado: (2016)

Comparison between pulse wave velocities measured using Complior and measured using Biopac
por: van Velzen, Marit H. N., et al.
Publicado: (2018)

Reduced acute myocardial ischemia–reperfusion injury in IL-6-deficient mice employing a closed-chest model
por: Jong, Willeke M. C., et al.
Publicado: (2016)

Sodium Glucose Co-Transporter 2 Inhibitors Ameliorate Endothelium Barrier Dysfunction Induced by Cyclic Stretch through Inhibition of Reactive Oxygen Species
por: Li, Xiaoling, et al.
Publicado: (2021)

ISOLATION OF PURE HEXOKINASE FROM YEAST
por: Berger, Louis, et al.
Publicado: (1946)

ISOLATION OF HEXOKINASE FROM BAKER'S YEAST
por: Berger, Louis, et al.
Publicado: (1946)

Regulation and Cytoprotective Role of Hexokinase III
por: Wyatt, Eugene, et al.
Publicado: (2010)

Functional domains of yeast hexokinase 2
por: Peláez, Rafael, et al.
Publicado: (2010)

HEXOKINASE ACTIVITY FROM EGGS OF THE SEA URCHIN ARBACIA PUNCTULATA
por: Krahl, M. E., et al.
Publicado: (1954)

Cannot write session to /tmp/vufind_sessions/sess_jk2md2sm0cq0abe25pe41ahr7k